Pancreatic Cancer Research

ResearcherPhilipps University of MarburgNo recent work listed

Hans Morreau

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5083-532X; OpenAlex author ID A5083885781, A5111971466. Sources: OpenAlex.

Their work

Papers
16 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
59
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 2 papers · 2014: none · 2015: none · 2016: 2 papers · 2017: 4 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 4 papers · 2023: 1 paper

Papers 16

  1. Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis. Co-author DOI 10.1053/j.gastro.2023.02.032↗
  2. Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study. Co-author DOI 10.1093/bjs/znac272↗
  3. Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry. Co-author DOI 10.1136/jitc-2022-004638↗
  4. Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up. Co-author DOI 10.1200/jco.22.00194↗
  5. A Paradoxical Role for Regulatory T Cells in the Tumor Microenvironment of Pancreatic Cancer. Co-author DOI 10.3390/cancers14163862↗
  6. High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers. Co-author DOI 10.1158/1940-6207.capr-18-0035↗
  7. Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancer. Co-author DOI 10.1007/s10689-016-9915-3↗
  8. Targeted next-generation sequencing of FNA-derived DNA in pancreatic cancer. Last author DOI 10.1136/jclinpath-2016-203928↗
  9. Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells. Co-author DOI 10.1177/1177271917715443↗
  10. Validation of full-field optical coherence tomography in distinguishing malignant and benign tissue in resected pancreatic cancer specimens. Co-author DOI 10.1371/journal.pone.0175862↗
  11. Selecting Tumor-Specific Molecular Targets in Pancreatic Adenocarcinoma: Paving the Way for Image-Guided Pancreatic Surgery. Co-author DOI 10.1007/s11307-016-0959-4↗
  12. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers. Co-author DOI 10.1200/jco.2015.64.0730↗
  13. Reduced expression of bone morphogenetic protein receptor IA in pancreatic cancer is associated with a poor prognosis. Co-author DOI 10.1038/bjc.2013.486↗
  14. Variation in precursor lesions of pancreatic cancer among high-risk groups. Co-author DOI 10.1158/1078-0432.ccr-12-2730↗
  15. Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report. Co-author DOI 10.1016/j.humpath.2011.06.008↗
  16. Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. Co-author DOI 10.1053/j.gastro.2010.11.048↗

Closest collaborators

The 25 strongest of 59 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bert A. Bonsing · 14 shared papers, 2011–2023 · strength 1.14
  2. Hans F. A. Vasen · 8 shared papers, 2011–2023 · strength 0.57
  3. Alexander L. Vahrmeijer · 6 shared papers, 2016–2022 · strength 0.52
  4. Martin N.J.M. Wasser · 7 shared papers, 2011–2023 · strength 0.51
  5. J. Sven D. Mieog · 5 shared papers, 2016–2023 · strength 0.45
  6. Thomas P. Potjer · 5 shared papers, 2013–2023 · strength 0.41
  7. Noel F.C.C. de Miranda · 3 shared papers, 2013–2022 · strength 0.32
  8. Isaura S. Ibrahim · 4 shared papers, 2016–2022 · strength 0.30
  9. Thomas P. Brouwer · 2 shared papers, 2022 · strength 0.28
  10. Jeanin Elise van Hooft · 2 shared papers, 2022–2023 · strength 0.28
  11. Bas Boekestijn · 2 shared papers, 2022–2023 · strength 0.28
  12. Monique Esther van Leerdam · 2 shared papers, 2022–2023 · strength 0.28
  13. Derk C.F. Klatte · 2 shared papers, 2022–2023 · strength 0.28
  14. Frederike Dijk · 2 shared papers, 2022 · strength 0.26
  15. Rutger‐Jan Swijnenburg · 3 shared papers, 2016–2017 · strength 0.18
  16. G. Johan A. Offerhaus · 3 shared papers, 2011–2022 · strength 0.17
  17. Wouter H. de Vos tot Nederveen Cappel · 4 shared papers, 2011–2018 · strength 0.16
  18. Lydia G. van der Geest · 1 shared paper, 2023 · strength 0.15
  19. Ricki T. Krog · 1 shared paper, 2022 · strength 0.14
  20. Susanna W.L. de Geus · 2 shared papers, 2016–2017 · strength 0.12
  21. Peter J.K. Kuppen · 2 shared papers, 2016–2017 · strength 0.12
  22. Cornelis F.M. Sier · 2 shared papers, 2016–2017 · strength 0.12
  23. Mark P.G. Dings · 1 shared paper, 2022 · strength 0.12
  24. Izaak Quintus Molenaar · 1 shared paper, 2022 · strength 0.12
  25. Jesse V. Groen · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.